In recent years immune responsiveness to selected synthetic polymers and copolymers of a-amino acids1-and to some native proteins 7-9 has been shown to be controlled largely by individual autosomal dominant genes, referred to as "specific immune response genes."6 The immune response of guinea pigs to several simple synthetic polyamino acid antigens (poly-L-lysine,' poly-L-arginine9), to a copolymer of L-glutamic acid and L-lysine, and to hapten conjugates of these polypeptides is dependent upon the presence of an autosomal dominant gene which is referred to as the poly-L-lysine (PLL) t gene.2 The PLL gene is found in all inbred strain 2 guinea pigs as well as in a varying percentage of randombred Hartley strain guinea pigs (responders) and is lacking in all inbred strain 13 guinea pigs (nonresponders). Hybrid (2 X 13)F1 guinea pigs are all responders and are heteroxygous for the gene. In mice, the immune response to a series of branched synthetic polypeptides containing random sequences of L-glutamic acid and i-tyrosine, or L-histidine, or L-phenylalanine, on a backbone of D,Lalanine and L-lysine [ 
(T,G)-A-L, (H-G)-A-L, (Phe,G)-A-L]
has been shown to be largely determined by single dominant alleles at a single locus referred to as Ir-1 or by three closely linked genes.6 10 Similarly, the immune response of mice to a random copolymer of L-glutamic acid and L-lysine containing 5% L-alanine is under the control of another dominant gene.4
Whereas specific immune response genes in mice have been shown not to be related to structural genes controlling allotypic markers of immunoglobulins,6 a most interesting observation has been made concerning the relationship of these genes with loci controlling major transplantation antigens in mice and guinea pigs: (1) Freund's adjuvant (CFA) was obtained from Difco Laboratories Inc., Detroit, Mich., and contained 0.5 mg/ml M. butyricum.
Preparation of conjugates: DNP82-PLL and DNP6-KLH were prepared by reacting PLL and KLH with 2,4-dinitrofluorobenzene under alkaline conditions as described previo~tsly.'4 The subscripts refer to the average number of DNP groups per molecule of PLL and per 100,000 mol wt units of KLH, respectively. 'H-DNP-EACA was prepared by the reaction ofeaminocaproic acid (EACA) with 'H-DNFB.15 125I BSA was prepared as described in ref. 16. Immunization: Guinea pigs were injected in the four foot pads with 0.2 ml of the antigen solutions in 0.15 M NaCl and 1% normal guinea pig serum, emulsified with an equal volume of Freund's adjuvant. The doses of antigen injected are shown in the respective tables and figures.
The animals were bled from the retro-orbital plexus 3-4 weeks after immunization. Delayed hypersensitivity reactions were evaluated 24 hr after the intradermal injection binding of 125I BSA, 8H insulin, and 3H-DNP-EACA respectively to the globulin fraction of the antisera was measured. For the anti-BSA and anti-DNP antibody assays, the globulin fraction was precipitated by 45% saturated (NH4)2 S04.18 A sheep anti-guinea pig gamma globulin antibody was used to precipitate antibody-bound porcine insulin in the antiinsulin antibody assay.
The data are expressed as the percentage of binding of the radioactive ligands by the undiluted antisera and by '/lo or l/loo dilutions of the antisera. PLL gene status of Hartley and (2 X 13)F1 X 13 animals: To determine the PLL gene status of animals after their response to BSA and insulin, the animals were immunized intradermally with 0.1 mg DNP-PLL in CFA and tested 14 days later for delayed hypersensitivity to DNP-PLL. In addition, they were bled and the anti-DNP antibody concentration of their sera was determined as described above. '8 Results. (1) The response of inbred strains of guinea pigs to BSA, DNP-KLH, and porcine insulin: The antibody responses of strains 2 and 13 guinea pigs 3-4 weeks after immunization with doses of BSA ranging from 100 to 0.1 ugg are presented in Figure 1 . The responses of the two inbred strains to 100 g (9) are expressed as percentage of binding 20 (4 13 antisera although the differences were not as marked as those observed in response to low doses of BSA (Fig. 1) . The data in Table 3 demonstrate that strain 13 animals respond equally well if not better than strain 2 guinea pigs to porcine insulin.
(2) The response of random-bred Hartley strain guinea pigs to low doses of BSA: The data presented in section (1) have demonstrated genetically controlled differences in the response of inbred guinea pigs to low doses of BSA, and have shown that responsiveness in this dose range is associated with the presence of the PLL gene. As the PLL gene is also found in some but not all random-bred Hartley strain animals, it is relevant to inquire whether individual Hartley strain guinea pigs differ in their ability to respond to low doses of BSA and whether such differences are again related to the possession of the PLL gene. Type II PLL nonresponders produced either very low or undetectable amounts of anti-BSA antibody just as strain 13 guinea pigs similarly immunized (Fig. 3) .
Discussion. Differences in the antibody response to limiting doses of a native protein antigen, BSA, can be demonstrated between two inbred strains of guinea pigs; these differences disappear when higher immunizing doses are used. Responsiveness to low doses of BSA, a property of strain 2 but not of strain 13 guinea pigs, was shown to be inherited in the progeny of the mating of (2 X 13)-F1 X 13 backcross together with the PLL gene, and therefore with strain 2 histocompatibility genotype which is also linked to the PLL gene.
These observations raise several questions: (1) The genetic difference in the ability to respond to relatively small amounts of BSA which distinguishes strain 2 from strain 13 animals may reflect their responses towards all foreign proteins or only towards some of these antigens. The mechanism by which immune responses controlled by individual autosomal genes are induced to relatively simple polypeptide antigens or to more complex proteins such as BSA and the processes controlled by these genes are still matters for speculation; nevertheless, certain avenues of approach appear promising. As it seems extremely unlikely that specific immune response genes code for the structure of specific immunoglobulins, one must consider a hypothesis such as proposed recently by Jerne20 for the generation of diversity in immunoglobulins by histocompatibility antigens, or alternatively postulate an additional level of cell-antigen interaction for the recognition of immunogenicity. The close linkage of immune response genes with histocompatibility genotypes should have considerable significance in this latter respect and suggests that if indeed both genetic factors are identical, histocompatibility antigens on classes of lymphocytes may affect the specific binding of antigens or the ability of these specific cells to be stimulated, since transfer experiments have established that lymphoid cells appear to be the cells where "immune response genes" are expressed.21-23
